, Columnist
Does the World Need Another Megadeal?
Stryker's reported pursuit of Boston Scientific is all about size, but bigger isn't better.
Sure you want to capture this flag, Stryker?
Photographer: JB REED/Bloomberg
This article is for subscribers only.
Three years and more than $3 trillion worth of megadeals later, investors may well wonder if bigger is better.
Shares of Boston Scientific Corp. spiked 7.4 percent on Monday after the Wall Street Journal reported that fellow medical-device maker Stryker Corp. had offered to acquire it. It's unclear how Boston Scientific feels about a deal, if in fact there's one on offer. Following the report, shares of both companies were halted for "news" that ended up being a Boston Scientific statement acknowledging the story and saying it doesn't comment on speculation. Cool.